Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2015, Vol. 44 Issue (2): 174-178    DOI: 10.3785/j.issn.1008-9292.2015.03.009
原著     
细胞周期蛋白依赖激酶抑制剂诱导HL-60细胞凋亡及分子机制研究
韩艳霞1,2, 尤良顺1, 刘辉1, 毛莉萍1, 叶琇锦1, 钱文斌1
1. 浙江大学医学院附属第一医院血液科, 浙江 杭州 310003;
2. 嘉兴市第二医院血液科, 浙江 嘉兴 314000
Apoptosis of acute myeloid leukemia HL-60 cells induced by CDK inhibitor SNS-032 and its molecular mechanisms
HAN Yan-xia1,2, YOU Liang-shun1, LIU Hui1, MAO Li-ping1, YE Xiu-jin1, QIAN Wen-bin1
1. Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
2. Department of Hematology, Jiaxing Second People's Hospital, Jiaxing 314000, China
 全文: PDF(740 KB)   HTML ( ) 
摘要：

目的:探讨细胞周期蛋白依赖激酶(CDK)抑制剂SNS-032诱导人急性髓系白血病HL-60细胞凋亡的效应及可能的机制。 方法:以CDK抑制剂SNS-032作用于HL-60细胞株,实验细胞分为对照组、SNS-032组、白细胞介素(IL)-6组和SNS-032+IL-6组。MTT法检测细胞存活率,流式细胞术检测细胞凋亡, microRNA芯片技术分析细胞microRNA的表达谱差异,蛋白质印迹法检测JAK/STAT3相关信号通路蛋白的表达。 结果:SNS-032可降低细胞存活率,诱导HL-60细胞凋亡,对照组、100nmol/L和200nmol/L的SNS-032干预组细胞凋亡率分别为(5.9±1.7)%、(12.1±3.1)%和(59.4±3.6)%。microRNA芯片分析结果显示,SNS-032显著下调HL-60细胞miR-30a、miR-183、miR-20b、miR-26b、miR-20a、miR-589、miR-107、miR-181a、miR-106a、miR-17和miR-378c的表达水平,显著上调miR-320a的表达水平。蛋白质印迹法显示SNS-032可抑制STAT3的磷酸化和JAK2、MCL-1、C-MYC蛋白的表达。作为JAK/STAT3通路的激活剂,IL-6联合SNS-032不能逆转后者对HL-60细胞的杀伤作用(P>0.05),也不能逆转SNS-032对JAK2蛋白表达和磷酸化STAT3的抑制作用。结论:SNS-032能显著诱导人急性髓系白血病 HL-60细胞发生凋亡,其机制可能与抑制JAK2和STAT3磷酸化、抑制MCL-1和C-MYC及与之相关的miR-17-92基因簇表达水平有关。
关键词： 白血病,髓样,急性;  微RNAs;  细胞周期蛋白质依赖激酶类/生物合成;  Janus激酶类;  STAT3转录因子;  蛋白酪氨酸激酶类/代谢;  信号传导;  HL-60细胞;  细胞凋亡;  肿瘤细胞,培养的    
Abstract:

Objective: To investigate the effects of cycle-dependent kinase (CDK) inhibitor SNS-032 on apoptosis in human acute myeloid leukemia (AML) HL-60 cells and its molecular mechanisms. Methods: Cultured AML HL-60 cells were treated with various concentrations of SNS-032. Cell apoptosis was determined with flow cytometry;cell viability was measured by MTT assay; the profiles of microRNA expression of HL-60 cells were analyzed by microRNA microarray;the protein expressions of JAK2/STAT3 pathway were detected by Western blotting. Results: Apoptosis of AML HL-60 cells was induced by SNS-032; the rate of apoptosis was (5.9±1.7)%, (12.1±3.1)% and (59.4±3.6)% when HL-60 cells were treated with 0,100 and 200 nmol/L SNS-032. MicroRNA microarray analysis revealed that the levels of miR-30a, miR-183, miR-20b, miR-26b, miR-20a, miR-589, miR-107, miR-181a, miR-106a, miR-17 and miR-378c were down-regulated by SNS-032,whereas the levels of miR-320a and miR-H7* were up-regulated. Western blotting showed that SNS-032 strongly inhibited phosphorylation of STAT3 and protein expression of JAK2,C-MYC and MCL-1. Conclusion: CDK inhibitor SNS-032 can induce apoptosis of AML HL-60 cells, which is associated with the inhibition of MCL-1,C-MYC and JAK2/STAT3, and down-regulation of miR-17-92 family.
Key words: Leukemia, myeloid, acute    MicroRNAs    Cyclin-dependent kinases/ biosynthesis    Janus kinases    STAT3 transcription factor    Protein-tyrosine kinases/metabolism    Signal transduction    HL-60 cells    Apoptosis    Tumor cells, cultured
收稿日期: 2014-09-05 出版日期: 2015-03-25
:  R552  
基金资助:

高等学校博士学科点专项科研基金(20120101110010);浙江省科技厅项目(2011C23014);浙江省医药卫生科技计划(2013KYA083);浙江省中医药管理局科技计划(2013ZA074)
通讯作者: 钱文斌(1964-),男,博士,主任医师,教授,博士生导师,主要从事血液病基础和临床研究;E-mail:qianwenb@hotmail.com     E-mail: qianwenb@hotmail.com
作者简介: 韩艳霞(1976-),女,硕士研究生,副主任医师,主要从事血液病基础和临床研究;E-mail:hanyanxia@tom.com
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
韩艳霞
尤良顺
刘辉
毛莉萍
叶琇锦
钱文斌

引用本文:

韩艳霞, 尤良顺, 刘辉, 毛莉萍, 叶琇锦, 钱文斌. 细胞周期蛋白依赖激酶抑制剂诱导HL-60细胞凋亡及分子机制研究[J]. 浙江大学学报（医学版）, 2015, 44(2): 174-178.

HAN Yan-xia, YOU Liang-shun, LIU Hui, MAO Li-ping, YE Xiu-jin, QIAN Wen-bin. Apoptosis of acute myeloid leukemia HL-60 cells induced by CDK inhibitor SNS-032 and its molecular mechanisms. Journal of ZheJiang University(Medical Science), 2015, 44(2): 174-178.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2015.03.009    或    http://www.zjujournals.com/med/CN/Y2015/V44/I2/174

[1] ASGHAR U, WITKIEWICZ A K, TURNER N C, et al. The history and future of targeting cyclin-dependent kinases in cancer therapy [J]. Nat Rev Drug Discov, 2015, 14(2):130-146.
[2] KUMAR S K, LAPLANT B, CHNG W J, et al. Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma [J]. Blood, 2015, 125(3):443-448.
[3] DICKSON M A. Molecular pathways:CDK4 inhibitors for cancer therapy [J]. Clin Cancer Res, 2014, 20(13):3379-3383.
[4] CHEN R, WIERDA W G, CHUBB S, et al. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia [J]. Blood, 2009, 113(19):4637-4645.
[5] WALSBY E, LAZENBY M, PEPPER C, et al. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine [J]. Leukemia, 2011, 25(3):411-419.
[6] LEE Y, AHN C, HAN J, et al. The nuclear RNase III Drosha initiates microRNA processing [J]. Nature, 2003, 425(6956):415-419.
[7] DENLI A M, TOPS B B, PLASTERK R H, et al. Processing of primary microRNAs by the Microprocessor complex [J]. Nature, 2004, 432(7014):231-235.
[8] LI Z, LU J, SUN M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations [J]. Proc Natl Acad Sci USA, 2008, 105(40):15535-15540.
[9] DIXON-MCIVER A, EAST P, MEIN C A, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia [J]. PLoS One, 2008, 3(5):e2141.
[10] JIN H Y, LAI M, XIAO C. microRNA-17～92 is a powerful cancer driver and a therapeutic target [J]. Cell Cycle, 2014, 13(4):495-496.
[11] XIANG J, WU J. Feud or friend？ The role of the miR-17-92 cluster in tumorigenesis [J]. Curr Genomics, 2010, 11(2):129-135.
[12] CHANG Q, BOURNAZOU E, SANSONE P, et al. The IL-6/JAK/STAT3 feed-forward loop drives tumorigenesis and metastasis [J]. Neoplasia, 2013, 15(7):848-862.
[1] 梁刚,牛育苗,李一涵,魏安怡,董静尹,曾玲晖. 雷帕霉素在大鼠局灶性脑缺血再灌注后24 h给药对脑损伤的保护作用[J]. 浙江大学学报（医学版）, 2018, 47(5): 443-449.
[2] 蔺莹,姚璎珈,梁喜才,时悦,孔亮,肖洪贺,吴雨桐,倪颖男,杨静娴. 蛇床子素通过上调微RNA-101a-3p抑制阿尔茨海默病细胞淀粉样前体蛋白表达[J]. 浙江大学学报（医学版）, 2018, 47(5): 473-479.
[3] 林卡娜,林美丽,顾莹芬,张顺国,黄诗颖. G蛋白偶联受体17在视网膜神经节细胞缺氧损伤中的作用[J]. 浙江大学学报（医学版）, 2018, 47(5): 487-492.
[4] 朱锋,范苗,徐孜惟,蔡依廷,陈益臻,余双,曾玲晖. 雷帕霉素对帕金森病小鼠的保护作用[J]. 浙江大学学报（医学版）, 2018, 47(5): 465-472.
[5] 林美娜,许瑞元,章涛,张琳,梅序桥. 类风湿关节炎患者外周血单个核细胞中c-FLIP与外源性凋亡途径的相关性分析[J]. 浙江大学学报（医学版）, 2018, 47(4): 381-388.
[6] 钱波,张彦玲,莫绪明. 先天性食管闭锁相关转录因子及信号通路研究进展[J]. 浙江大学学报（医学版）, 2018, 47(3): 239-243.
[7] 田广烽,高慧,胡莎莎,舒强. 遗传和表观遗传机制在先天性心脏病中的研究进展[J]. 浙江大学学报（医学版）, 2018, 47(3): 227-238.
[8] 李福山,房冉,饶琳,孟飞龙,赵小立. 外泌体在心血管疾病诊疗中的作用研究进展[J]. 浙江大学学报（医学版）, 2018, 47(3): 320-326.
[9] 潘宗富,方琦璐,张轶雯,李莉,黄萍. 基于生物信息学的未分化甲状腺癌关键发病机制及其潜在干预靶点研究[J]. 浙江大学学报（医学版）, 2018, 47(2): 187-193.
[10] 刘婷婷,王凌霄,杨晓辉,姚智卿,蔡慧珍. MyD88非依赖性信号通路在枸杞多糖抑制糖尿病小鼠肿瘤坏死因子α中的作用[J]. 浙江大学学报（医学版）, 2018, 47(1): 35-40.
[11] 丁京京,卢韵碧. 受体相互作用蛋白家族在炎症中的作用研究进展[J]. 浙江大学学报（医学版）, 2018, 47(1): 89-96.
[12] 魏振龙,石文贵,陈克明,周建,王鸣刚. 淫羊藿素通过CXCR4/SDF-1信号通路促进小鼠成骨细胞成熟和矿化[J]. 浙江大学学报（医学版）, 2017, 46(6): 571-577.
[13] 张谊,张璃,张启瑜,洪炜龙,林孝华. 微小RNA222靶向调控基质金属蛋白酶1促进增生性瘢痕组织成纤维细胞生长[J]. 浙江大学学报（医学版）, 2017, 46(6): 609-617.
[14] 姜贻乾 等. 微小RNA-29b对乳腺癌细胞增殖和迁移的影响及其分子生物学机制[J]. 浙江大学学报（医学版）, 2017, 46(4): 349-356.
[15] 田华 等. CD97免疫表位对乳腺癌细胞株MDA-MB231生物学行为的影响[J]. 浙江大学学报（医学版）, 2017, 46(4): 341-348.